Stoke Therapeutics, Inc. STOK Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Stoke Therapeutics, Inc.’s reported figures.
The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Stoke Therapeutics, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Stoke Therapeutics, Inc.'s enterprise value?
- Stoke Therapeutics, Inc. (STOK) reported enterprise value of $1.77B in Q1 2026.
- How has Stoke Therapeutics, Inc.'s enterprise value changed year-over-year?
- Stoke Therapeutics, Inc.'s enterprise value increased by 1854.5% year-over-year, from $90.75M to $1.77B.
- What is the long-term trend for Stoke Therapeutics, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s enterprise value has grown at a -2.8% compound annual growth rate (CAGR), from $1.99B to $1.73B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.